Refine
Year of publication
Document Type
- Article (1343)
- Conference Proceeding (208)
- Book (43)
- Part of a Book (40)
- Doctoral Thesis (18)
- Other (5)
- Patent (4)
- Preprint (3)
- Lecture (2)
- Habilitation (1)
- Talk (1)
Language
- English (1668) (remove)
Keywords
- Biosensor (25)
- Finite-Elemente-Methode (12)
- Einspielen <Werkstoff> (10)
- CAD (8)
- civil engineering (8)
- Bauingenieurwesen (7)
- FEM (6)
- Limit analysis (6)
- Shakedown analysis (6)
- shakedown analysis (6)
- Clusterion (5)
- Air purification (4)
- Hämoglobin (4)
- LAPS (4)
- Lipopolysaccharide (4)
- Luftreiniger (4)
- Natural language processing (4)
- Plasmacluster ion technology (4)
- Raumluft (4)
- hydrogen peroxide (4)
Institute
- Fachbereich Medizintechnik und Technomathematik (1668) (remove)
A variety of transition metals, e.g., copper, zinc, cadmium, lead, etc. are widely used in industry as components for wires, coatings, alloys, batteries, paints and so on. The inevitable presence of transition metals in industrial processes implies the ambition of developing a proper analytical technique for their adequate monitoring. Most of these elements, especially lead and cadmium, are acutely toxic for biological organisms. Quantitative determination of these metals at low activity levels in different environmental and industrial samples is therefore a vital task. A promising approach to achieve an at-side or on-line monitoring on a miniaturized and cost efficient way is the combination of a common potentiometric sensor array with heavy metal-sensitive thin-film materials, like chalcogenide glasses and polymeric materials, respectively.
The discovery of human induced pluripotent stem cells reprogrammed from somatic cells [1] and their ability to differentiate into cardiomyocytes (hiPSC-CMs) has provided a robust platform for drug screening [2]. Drug screenings are essential in the development of new components, particularly for evaluating the potential of drugs to induce life-threatening pro-arrhythmias. Between 1988 and 2009, 14 drugs have been removed from the market for this reason [3]. The microelectrode array (MEA) technique is a robust tool for drug screening as it detects the field potentials (FPs) for the entire cell culture. Furthermore, the propagation of the field potential can be examined on an electrode basis. To analyze MEA measurements in detail, we have developed an open-source tool.